Inhaled Nitric Oxide in Patients with Severe COVID-19 Infection at Intensive Care Unit – A Cross Sectional Study

1Gurgueira G, Carvalho WB. Inhaled nitric oxide: clinical application. J Pneumol. 2003;29(5):325–31. Gurgueira G Carvalho WB Inhaled nitric oxide: clinical application J Pneumol 200329 5 325 3110.1590/S0102-35862003000500012Search in Google Scholar

2Grifiths MJD, Mcauley DF, Perkins GD, Barrett N, Blackwood B, Boyle A, et al. Guidelines on the management of acute respiratory distress syndrome. BMJ Open Resp Res. 2019;(6:e000420). Grifiths MJD Mcauley DF Perkins GD Barrett N Blackwood B Boyle A et al Guidelines on the management of acute respiratory distress syndrome BMJ Open Resp Res 2019 6e00042010.1136/bmjresp-2019-000420656138731258917Search in Google Scholar

3Care I, Papazian L, Aubron C, Brochard L, Chiche JD, Combes A, et al. Formal guidelines: management of acute respiratory distress syndrome. Ann Intensive Care [Internet]. 2019;(9:69). Care I Papazian L Aubron C Brochard L Chiche JD Combes A et al Formal guidelines: management of acute respiratory distress syndrome Ann Intensive Care [Internet] 2019 96910.1186/s13613-019-0540-9656576131197492Search in Google Scholar

4Chen L, Liu P, Gao H, Sun B, Chao D, Wang F, et al. Inhalation of Nitric Oxide in the Treatment of Severe Acute Respiratory Syndrome : A Rescue Trial in Beijing. Clin Infect Dis. 2004;39:1531–5. Chen L Liu P Gao H Sun B Chao D Wang F et al Inhalation of Nitric Oxide in the Treatment of Severe Acute Respiratory Syndrome : A Rescue Trial in Beijing Clin Infect Dis 2004391531 510.1086/425357710789615546092Search in Google Scholar

5Keyaerts E, Vijgen L, Chen L, Maes P, Hedenstierna G, Ranst M Van. Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine , a nitric oxide donor compound. Int J Infec Dis. 2004;(8):223–6. Keyaerts E Vijgen L Chen L Maes P Hedenstierna G M Van Ranst Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine , a nitric oxide donor compound Int J Infec Dis 2004 8 223–610.1016/j.ijid.2004.04.012712897515234326Search in Google Scholar

6Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, et al. Surviving Sepsis Campaign : Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19). Vol. 2019. 2020. 1–32 p. Alhazzani W Møller MH Arabi YM Loeb M Gong MN Fan E et al Surviving Sepsis Campaign : Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) Vol. 2019 2020 1–32Search in Google Scholar

7Covid- S, Martinez FJ. Severe Covid-19. NEJM. 2020;1–10. S Covid- FJ Martinez Severe Covid-19 NEJM 20201–1010.1177/1536504220977927Search in Google Scholar

8Kobayashi J, Murata I. Nitric oxide inhalation as an interventional rescue therapy for COVID ‑ 19 ‑ induced acute respiratory distress syndrome. Ann Intensive Care [Internet]. 2020;(10:61):9–10. Kobayashi J Murata I Nitric oxide inhalation as an interventional rescue therapy for COVID ‑ 19 ‑ induced acute respiratory distress syndrome Ann Intensive Care [Internet] 2020 1061 9–1010.1186/s13613-020-00681-9723839432436029Search in Google Scholar